Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy

MLA

Kang Ling Wang, et al. “Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy.” The Canadian Journal of Cardiology, vol. 32, no. 10, July 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....844a0c4297541b8ffc181fd881f5ccad&authtype=sso&custid=ns315887.

APA

Kang Ling Wang, Shih Hwa Chiou, Yuh Lih Chang, Chen Yuan Hsiao, Ying Hsiu Lai, Yueh Chien, Wen Chung Yu, Chien Ying Wang, Shing Jong Lin, Hsin Bang Leu, Kuan Hsuan Chen, & Dau Ming Niu. (2015). Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy. The Canadian Journal of Cardiology, 32(10).

Chicago

Kang Ling Wang, Shih Hwa Chiou, Yuh Lih Chang, Chen Yuan Hsiao, Ying Hsiu Lai, Yueh Chien, Wen Chung Yu, et al. 2015. “Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy.” The Canadian Journal of Cardiology 32 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....844a0c4297541b8ffc181fd881f5ccad&authtype=sso&custid=ns315887.